Jump to main content
Jump to site search

Issue 10, 2017
Previous Article Next Article

PSMA-targeted contrast agents for intraoperative imaging of prostate cancer,

Author affiliations

Abstract

Prostate-specific membrane antigen (PSMA) can serve as a molecular cell surface target for the detection and treatment of prostate cancer. Near-infrared (NIR) fluorescence imaging enables highly sensitive, rapid, and non-radioactive imaging of PSMA, though specific targeting still remains a challenge because no optimized contrast agents exist.

Graphical abstract: PSMA-targeted contrast agents for intraoperative imaging of prostate cancer,

Back to tab navigation

Supplementary files

Publication details

The article was received on 13 Dec 2016, accepted on 09 Jan 2017 and first published on 13 Jan 2017


Article type: Communication
DOI: 10.1039/C6CC09781B
Chem. Commun., 2017,53, 1611-1614

  •   Request permissions

    PSMA-targeted contrast agents for intraoperative imaging of prostate cancer,

    K. Bao, J. H. Lee, H. Kang, G. K. Park, G. El Fakhri and H. S. Choi, Chem. Commun., 2017, 53, 1611
    DOI: 10.1039/C6CC09781B

Search articles by author

Spotlight

Advertisements